An illustration of a heart with an Impella CP with SmartAssist in the left ventricular on a blue background with a light blue hash pattern on the right side.

First Completed RCT of Impella® in AMICS

The DanGer Shock RCT Found That Routine Use of Impella CP® Reduces All-Cause Mortality at 180 Days in AMI Cardiogenic Shock Due to STEMI Compared to the Standard of Care1

The FDA has granted Impella a Premarket Approval (PMA) for high-risk PCI, cardiogenic shock and right heart failure.

  • 1,200+

    Peer-reviewed clinical studies have published on Impella, including the PROTECT II randomized controlled trial

  • 13

    Clinical society guidelines include Impella heart pumps

  • 300,000+

    Patients have been treated with Impella heart pumps

 

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Mir B. Basir, DO, discusses best practices from the National Cardiogenic Shock Initiative (NCSI) Study.

Portrait of a doctor in a white coat speaking to a patient

For Interventional Cardiologists

Treat high-risk PCI, cardiogenic shock and right heart failure patients

Portrait of a surgeon in the operating room

For Cardiac and Vascular Surgeons

Escalate, stabilize and recover native organs with minimally-invasive surgical techniques

Portrait of a female nurse with a group of nurses blurred out in the background

For Nurses

Use calculators, watch quick skills videos and learn patient management best practices

An image of a young doctor in a white coat with colleagues in the background at a table

For Fellows

Advance your knowledge and develop skills to treat complex PCI patients

For Referring Providers

Are you caring for patients with heart disease? Learn more about how Impella heart pumps work, the benefits of Protected PCI with Impella and explore patient identification resources. 

Native Heart and Lung Recovery

White illustration of the hospital with a red cross

Conditions & Therapies

Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.

White illustration of the hands holding a red cross

Products & Services

Learn about the latest technology and how that technology may best support your patient.

White illustration of a screen showing graphs

Education & Resources

Abiomed provides a comprehensive training program for health care providers.

Subscribe to receive the latest clinical data and priority access to resources.

References

  1. Møller, J., et al. (2024). Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med.

NPS-1309

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].